Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer.

CONCLUSIONS: Neoadjuvant chemotherapy is a useful treatment to downsize tumour in early breast cancer, thereby increasing the rate of breast-conserving surgery. It is especially effective in patients with HER2-positive/oestrogen receptor-negative disease or triple-negative disease. PMID: 28484080 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28484080?dopt=Abstract

Source: Hong Kong Med J - May 9, 2017 Category: General Medicine Authors: Man VC, Cheung PS Tags: Hong Kong Med J Source Type: research